Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates
- 31 May 2005
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 45 (6) , 911-919
- https://doi.org/10.1111/j.1537-2995.2005.04350.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and lightTransfusion, 2004
- Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis plateletsVox Sanguinis, 2004
- Generation of annexin V‐positive platelets and shedding of microparticles with stimulus‐dependent procoagulant activity during storage of platelets at 4°CTransfusion, 2000
- In vitro Evaluation of the Hemostatic Effectiveness of Non Viable Platelet Preparations: Studies with Frozen‐Thawed, Sonicated or Lyophilized PlateletsVox Sanguinis, 1997
- Redistribution of membrane glycoproteins in platelets activated under flow conditionsBlood Coagulation & Fibrinolysis, 1996
- Platelet concentrates promote procoagulant activity: evidence from experimental studies using a perfusion techniqueTransfusion, 1995
- The role of the Baumgartner technique in transfusion medicine: research and clinical applicationsTransfusion, 1994
- Activation in stored platelet concentrates: correlation between membrane expression of P‐selectin, glycoprotein IIb/IIIa, and beta‐ thromboglobulin releaseTransfusion, 1993
- Platelet procoagulant activity: physiological significance and mechanisms of exposureBlood Reviews, 1991
- Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendotheliumNature, 1979